Practical medical manual of biomedicines used in the treatment of autoimmune diseases and in certain hemopathies.
This is an edition intended for medical and paramedical personnel.

Characteristics:
- Content available offline.
-Very simple, practical and free application.
-The main molecules and active ingredients.
-Ability to quickly search in the application (substance name or trade name)
-The necessary assessment before starting a biotherapy.
-Presentations, forms, premedication, dosage and rate of taking biotherapies.
-Availability, price and reimbursement (Morocco).
- Monitoring methods: Tolerance, efficacy and time to therapeutic response.
-Practical situations: what to do in case of trauma, burn, dental care, pregnancy or breastfeeding.
-Bibliographical references for each molecule (internet connection required).

List of molecules included:
- Anti-TNF: INFLIXIMAB, ETANERCEPT, ADALIMUMAB, GOLIMUMAB, CERTOLIZUMAB PEGOL…
- Anti-CD28: ABATACEPT
- Anti-IL1: ANAKINRA, CANAKINUMAB…
- Anti-IL6: TOCILIZUMAB, SARILUMAB, SILTUXIMAB ...
- Anti- (IL12 and IL23): USTEKINUMAB
- Anti-IL17: SECUKINUMAB, BRODALUMAB, IXEKIZUMAB…
- Anti-CD20: RITUXIMAB
- Anti-RANK ligand: DENOSUMAB
- Anti-BLyS: BELIMUMAB
- Anti-JAK: TOFACITINIB, BARICITINB, RUXOLITINIB, UPADACITINIB, FILGOTINIB…

Important Notes:
**** By installing this application, you automatically agree to the terms and rules of use:
1 - This is a free application, a practical guide to the use of biomedicines for staff and students in the medical and paramedical field of the specialties concerned.
2 - Disclaimer:
A - The content of the application comes from different sources (see References). The author accepts no responsibility for any unintentional error that may arise from a reference, a typo or a misunderstanding.
B - The author does not take any responsibility if damage has been caused to your device due to the application.
C - The author retains the right - at any time - to update, modify or delete the content of the application.
3 - Any reproduction must be made only after the consent of the author.

* Information *:
** The addition of other sections and molecules is planned in the next updates
** The indications, dosages, rate of administration and the therapeutic response category are currently available mainly for rheumatology. The addition of other information will be done regularly.
** Do not hesitate to contact us with the slightest concern or suggestion.
Written content and application engine developed by Doctor SOUHIL ERRAFIA (ERRAFIOS), doctor specializing in rheumatology.